首页> 美国卫生研究院文献>The Journal of Headache and Pain >Short-term efficacy and safety of lasmiditan a novel 5-HT1F receptor agonist for the acute treatment of migraine: a systematic review and meta-analysis

【2h】

Short-term efficacy and safety of lasmiditan a novel 5-HT1F receptor agonist for the acute treatment of migraine: a systematic review and meta-analysis

机译：新型5-HT1F受体激动剂拉米替坦对偏头痛的急性治疗的近期疗效和安全性：系统评价和荟萃分析

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Process of identifying eligible studies for the meta-analysis

机译：为荟萃分析确定合格研究的过程

著录项

期刊名称 The Journal of Headache and Pain
作者
Min Hou; Haiyan Xing; Chen Li; Xianfeng Wang; Dongmei Deng; Juan Li; Pan Zhang; Jianhong Chen;
展开▼
作者单位

展开▼
年(卷),期 2020(21),1
年度 2020
页码 -1
总页数 12
原文格式 PDF
正文语种
中图分类神经科学;神经病学;
关键词
Migraine; Lasmiditan; 5-HT;

机译：偏头痛;拉米坦;5-HT;
入库时间 2022-08-21 11:41:36

相似文献

外文文献
中文文献
专利

1. Short-term efficacy and safety of lasmiditan, a novel 5-HT1F receptor agonist, for the acute treatment of migraine: a systematic review and meta-analysis [J] . Min Hou, Haiyan Xing, Chen Li, The journal of headache and pain . 2020,第1期

机译：Lasmiditan的短期疗效和安全性，一种新的5-HT1F受体激动剂，用于偏头痛的急性治疗：系统审查和荟萃分析
2. The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine [J] . HochschulambulanzundKlinikfürNeurologieCharité-Universit?tsmedizinBerlin, DepartmentofNeurologyChariteUniversit?tsmedizinBerlinBerlin Therapeutic advances in neurological disorders. . 2015,第1期

机译：口服5-HT1F受体激动剂拉米替坦在偏头痛急性治疗中的药理作用及临床前景
3. The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine [J] . Uwe Reuter, Heike Israel, Lars Neeb Therapeutic advances in neurological disorders. . 2015,第1期

机译：口服5-HT1F受体激动剂拉米替坦在偏头痛急性治疗中的药理作用及临床前景
4. SAFETY AND USABILITY FACTORS IN DEVELOPMENT OF A NOVEL, AUTOMATED TREATMENT DEVICE FOR ACUTE MIGRAINE [C] . David M. George, Guido Pagnacco, Kevin E. Willey, Annual rocky mountain bioengineering symposium;International ISA biomedical sciences instrumentation symposium . 2017

机译：开发新型自动治疗急性偏头痛的安全性和可用性因素
5. A Systematic Review and Network Meta-Analysis of Emergency Department Migraine Treatment [D] . Westafer, Lauren M. 2018

机译：急诊科偏头痛治疗的系统综述与网络荟萃分析
6. The pharmacological profile and clinical prospects of the oral 5-HT1F receptor agonist lasmiditan in the acute treatment of migraine [O] . Uwe Reuter, Heike Israel, Lars Neeb 2015

机译：口服5-HT1F受体激动剂拉米替坦在偏头痛急性治疗中的药理作用及临床前景
7. The 5-HT1F receptor agonist lasmiditan as a potential treatment of migraine attacks: a review of two placebo-controlled phase II trials [O] . Tfelt-Hansen, Peer C., Olesen, Jes 2012

机译：5-HT1F受体激动剂拉米替坦可作为偏头痛的潜在治疗方法：两项安慰剂对照的II期临床试验的综述

Short-term efficacy and safety of lasmiditan a novel 5-HT1F receptor agonist for the acute treatment of migraine: a systematic review and meta-analysis

摘要

著录项

相似文献

相关主题

期刊订阅